Literature DB >> 15245880

Involvement of D1 dopamine receptors in the cognitive effects of angiotensin IV and des-Phe6 angiotensin IV.

Jan J Braszko1.   

Abstract

An important role for angiotensin IV (Ang IV) in the processes of learning and memory has now been well established. We have previously found that intracerebroventricular (ICV) administration of Ang IV as well as des-Phe6-Ang IV enhances learning of conditioned avoidance responses (CARs), facilitates recall of a passive avoidance (PA) task, and improves object recognition (OR) in rats. Since the dopaminergic system is crucial for the cognitive processes, in this study our aim was to determine the dopaminergic D1 mediation of these effects using SCH 23390 as a selective D1 receptor antagonist. Male Wistar rats (180-200 g), pretreated with SCH 23390 (R-[+]-7-chloro-8-hydroxy-3-methyl-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine) 0.05 mg/kg intraperitoneally (IP), were given Ang IV or des-Phe6-Ang IV (1 nmol ICV) 1 h later and then tested in the above cognitive paradigms, as well as in the open field and an elevated 'plus' maze to control for the unspecific, respectively, motor and emotional, effects of our treatments. Both, Ang IV and des-Phe6-Ang IV effectively enhanced learning of CARs (P < 0.05), recall of PA (P < 0.001), and improved OR (P < 0.001). Pretreatment with SCH 23390 abolished the cognitive effects of both peptides. SCH 23390, Ang IV, and des-Phe6-Ang IV, given at the same doses and routes as in the cognitive tests, did not significantly influence crossings, rearings and bar approaches in the open field, nor the parameters measured in the elevated 'plus' maze, thus making a major contribution of the unspecific effects of our treatments to the results of the memory tests improbable. In conclusion, these results indicate that the functional dopaminergic D1 receptors are necessary for the Ang IV and des-Phe6-Ang IV cognitive effects to occur.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245880     DOI: 10.1016/j.peptides.2004.04.014

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  10 in total

1.  Central administration of angiotensin IV rapidly enhances novel object recognition among mice.

Authors:  Jason J Paris; Shainnel O Eans; Elisa Mizrachi; Kate J Reilley; Michelle L Ganno; Jay P McLaughlin
Journal:  Neuropharmacology       Date:  2013-02-14       Impact factor: 5.250

2.  Candesartan prevents impairment of recall caused by repeated stress in rats.

Authors:  Jan Józef Braszko; Dominik Wincewicz; Piotr Jakubów
Journal:  Psychopharmacology (Berl)       Date:  2012-08-14       Impact factor: 4.530

Review 3.  Identification and development of specific inhibitors for insulin-regulated aminopeptidase as a new class of cognitive enhancers.

Authors:  Anthony L Albiston; Shanti Diwakarla; Ruani N Fernando; Simon J Mountford; Holly R Yeatman; Broden Morgan; Vi Pham; Jessica K Holien; Michael W Parker; Philip E Thompson; Siew Yeen Chai
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

Review 4.  Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review.

Authors:  Bart Stragier; Dimitri De Bundel; Sophie Sarre; Ilse Smolders; Georges Vauquelin; Alain Dupont; Yvette Michotte; Patrick Vanderheyden
Journal:  Heart Fail Rev       Date:  2007-11-08       Impact factor: 4.214

5.  The effect of angiotensin II and IV on ERK1/2 and CREB signalling in cultured rat astroglial cells.

Authors:  Adam Holownia; Jan J Braszko
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000

6.  Cognitive benefits of angiotensin IV and angiotensin-(1-7): A systematic review of experimental studies.

Authors:  Jean K Ho; Daniel A Nation
Journal:  Neurosci Biobehav Rev       Date:  2018-05-04       Impact factor: 8.989

7.  Evaluating the relationship of blood pressure, plasma angiotensin peptides and aldosterone with cognitive functions in patients with hypertension.

Authors:  Selçuk Sen; Nermin Gürel; Baran Ufuktepe; Zeynep Günes Özünal; Çagla Büyüklü; Yagiz Üresin
Journal:  EXCLI J       Date:  2017-03-10       Impact factor: 4.068

8.  Protective Effect of Renin-Angiotensin System Inhibitors on Parkinson's Disease: A Nationwide Cohort Study.

Authors:  Youngkwon Jo; Seungyeon Kim; Byoung Seok Ye; Euni Lee; Yun Mi Yu
Journal:  Front Pharmacol       Date:  2022-03-03       Impact factor: 5.810

Review 9.  Cognitive-enhancing effects of angiotensin IV.

Authors:  Paul R Gard
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

Review 10.  Development of cognitive enhancers based on inhibition of insulin-regulated aminopeptidase.

Authors:  Siew Yeen Chai; Holly R Yeatman; Michael W Parker; David B Ascher; Philip E Thompson; Hayley T Mulvey; Anthony L Albiston
Journal:  BMC Neurosci       Date:  2008-12-03       Impact factor: 3.288

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.